Patients aged 80 and older are often excluded from receiving the standard regimen for acute myeloid leukemia. However, research showed that some patients can tolerate the therapy. Some older patients ...

Opioid use disorder during pregnancy remains a critical yet under-addressed public health issue in the U.S., according to a ...

In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus pembrolizumab resulted in durable responses with improved progression free ...

This news might break your heart — literally. A shocking new study found that the go-to treatment doctors have been using to manage heart attacks for the last 40 years may offer no real benefit for ...

As a Canadian-born physician who has treated people with opioid use disorder on both sides of the U.S.-Canada border, I know that if I ever needed addiction treatment I’d head to the Great White North ...

Roche Holding said experimental drug giredestrant outperformed the standard-of-care treatment in a late-stage trial, showing significant improvements for breast-cancer patients. The Swiss pharma group ...

Researchers across 23 medical centers found a new two-dose treatment that could be as effective as standard treatment for complicated Staphylococcus aureus. The study was led by researchers from ...

In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus pembrolizumab resulted in durable responses with improved progression free ...